PRANATI SREEPATHY
CHICAGO, IL NPI 1013545888
Browse related groups: IL NOVARTIS PHARMACEUTICALS CORPORATION All categories
General Payments — all program years on this page
$182.29
- Category: General Payments
- Program years: PY2024
- Record count: 8
- As of (CMS publication): 2026-01-23
Latest program year (PY2024): $182.29 across 8 records · disputed records: 0
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How this figure is calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
Latest program year (PY2024) · sorted by reported total.
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $182.29 | 8 |
By paying entity
Latest program year (PY2024) · sorted by reported total.
| Paying entity | Amount | Records |
|---|---|---|
| NOVARTIS PHARMACEUTICALS CORPORATION | $98.25 | 3 |
| Acerta Pharma LLC | $32.74 | 2 |
| Medtronic, Inc. | $28.28 | 2 |
| CHIESI USA, INC. | $23.02 | 1 |
By program year
| Program year | Amount | Records |
|---|---|---|
| 2024 | $182.29 | 8 |
Records — PY2024 (8)
| Record ID | Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Source |
|---|---|---|---|---|---|---|---|
| 1087335395 | Novartis Pharmaceuticals Corporation | $19.54 | 07/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1087335419 | Novartis Pharmaceuticals Corporation | $18.15 | 08/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1087335431 | Novartis Pharmaceuticals Corporation | $60.56 | 12/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1110511092 | AstraZeneca Pharmaceuticals LP | $16.58 | 07/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1110516234 | AstraZeneca Pharmaceuticals LP | $16.16 | 08/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1116857455 | Medtronic, Inc. | $13.64 | 07/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1116857457 | Medtronic, Inc. | $14.64 | 07/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1151821667 | Chiesi USA, Inc. | $23.02 | 08/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
Provenance & corrections
- Dataset: CMS Open Payments — General Payments
- Source: CMS Open Payments dataset (bulk file)
- Publisher of source data: Centers for Medicare & Medicaid Services
- Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.